
Resources
-

Beyond deprescribing: Prioritizing health in GLP-1 care
GLP-1s have redefined what is clinically achievable in metabolic health. For millions of individuals, they represent a vital, life-altering treatment for obesity, type 2 diabetes, MASH, obstructive sleep apnea, and cardiovascular risk reduction. A well-constructed cardiometabolic strategy recognizes the immense value of these medications for the right patients, in the right clinical context.
-

Rethinking GLP-1 Strategy: New Approaches to Access, Cost, and Accountability
Watch the on-demand webinar for insights how leading employers and health plans are balancing GLP-1 expansion with cost management through innovative direct-to-employer strategies, actionable coverage frameworks, and proactive benefit designs.
-

The cost of discontinued care: Why GLP-1 coverage fails without clinical continuity
If your organization’s cardiometabolic health strategy begins and ends with GLP-1 coverage, you don’t really have a strategy. You have a pharmacy decision masquerading as population health.